Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
33,559,180
-
Share change
-
+406,400
-
Total reported value
-
$202,697,000
-
Price per share
-
$6.04
-
Number of holders
-
34
-
Value change
-
+$840,790
-
Number of buys
-
19
-
Number of sells
-
18
Institutional Holders of GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) as of Q4 2021
As of 31 Dec 2021,
GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,559,180 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, CAPITAL INTERNATIONAL INC /CA/, FRAZIER MANAGEMENT LLC, FEDERATED HERMES, INC., Vivo Capital, LLC, BlackRock Inc., and MORGAN STANLEY.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.